logo

Breaking News

Share SHARE

Finish Line Inc. (FINL) said that it still expects comparable store sales to increase in the low-single digits range and adjusted earnings per share to be between $1.12 and $1.23 for the 53 week fiscal year ending March 3, 2018. Analysts polled by Thomson Reuters expect the company to report earnings...

Accenture (ACN) said that it has completed the termination of its U.S. Pension Plan, which was previously announced in March 2016, by entering into agreements with American General Life Insurance Company or AGL - a subsidiary of American International Group Inc. (AIG) - and Massachusetts Mutual Life...

Novartis (NVS) announced the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending approval of Kisqali (ribociclib) in combination with an aromatase inhibitor for treatment of postmenopausal women with hormone receptor...

Novartis (NVS) announced results from additional analyses of the ENESTfreedom and ENESTop clinical trials, which found that about half of adult patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia or CML in the chronic phase or CP who discontinued Tasigna (nilotinib) remain in...

Novartis (NVS) announced updated results from the ELIANA clinical trial demonstrating CTL019 or tisagenlecleucel remission rates are maintained at six months in relapsed/refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia or ALL. These data from this pivotal...

Genentech, a member of the Roche Group (RHHBY), announced that it will present new post-hoc analyses from the OCREVUSTM (ocrelizumab) Phase III clinical trial program in people with relapsing and primary progressive forms of multiple sclerosis RMS and PPMS) at the 3rd Congress of the European Academy...

Novartis announced the US Food and Drug Administration or FDA approval of Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express the BRAF V600E mutation. The FDA also approved the Oncomine Dx Target Test...

Pfeiffer Vacuum Technology AG announced that its subsidiary Pfeiffer Vacuum Inc. (USA) acquired Nor-Cal Products Inc. (USA) for $68 million on a cash and debt-free basis. The purchase agreement was signed and executed and the transaction was mainly financed via a bank loan. With the acquisition...

After gapping open sharply lower, shares of Steelcase (SCS) continue to see significant weakness in late-day trading on Thursday.

Shares of Weibo (WB) have climbed well off their lows of the session but remain in the red in late-day trading on Thursday.

After gapping open sharply higher, shares of Oracle (ORCL) have pulled back off their best levels but remain firmly positive in afternoon trading on Thursday.

Swiss drug giant Novartis (NVS) continues to see considerable strength in afternoon trading on Thursday after an early move to the upside.

Shares of Barnes & Noble (BKS) are seeing significant strength in afternoon trading on Thursday, surging up by 6.9 percent

After trending lower in recent sessions, shares of Staples (SPLS) have shown a strong move back to the upside during trading on Thursday.

CenturyLink, Inc. (CTL) announced its new COO organizational structure will include five business units and several functional support groups. Edward Morche will be president - strategic enterprise, federal government and state government; Laurinda Pang will be president - GAM and international; Vernon...

Follow RTT